Brief: Applied Therapeutics Announces MAA Validation And NDA Submission Of Govorestat For Treatment Of Classic Galactosemia
03/01/2024 12:08
Jan 3 (Reuters) - Applied Therapeutics Inc APLT.O :
* APPLIED THERAPEUTICS ANNOUNCES MAA VALIDATION AND NDA
SUBMISSION
OF GOVORESTAT (AT-007) FOR TREATMENT OF CLASSIC GALACTOSEMIA
* APPLIED THERAPEUTICS INC - NDA SUBMITTED TO FDA AND MAA
VALIDATED BY EMA IN DECEMBER 2023
* APPLIED THERAPEUTICS INC - MAA HAS BEEN VALIDATED AND WILL
MOVE
TO REVIEW BY EMA'S COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN
USE
Source text for Eikon: ID:nGNX20n3Dm
Further company coverage: APLT.O
((Reuters.Briefs@thomsonreuters.com;))